21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
20.14.Z - Manufacture of other organic basic chemicals
20.59.Z - Manufacture of other chemical products, not elsewhere classified
21.10.Z - Manufacture of basic pharmaceutical products
46.46.Z - Wholesale trade of pharmaceutical and medical products
68.10.Z - Real estate activities on own account and development of building projects
68.20.Z - Rental and management of own or leased real estate
71.20.B - Inspection and issuing opinions on the technical condition of chimneys and ventilation ducts
72.11.Z - Scientific research and development activities
72.19.Z - Scientific research and development activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Assets | 233,2 | 237,1 | 227,5 | -4 |
Gross profit (loss) | -59,5 | -18 | -24,4 | -35,6 |
Net profit (loss) | -59,5 | -18 | -24,4 | -35,6 |
Liabilities and provisions for liabilities | 287,7 | 309,6 | 324,4 | 4,8 |
Income tax | 0 | 0 | 0 | 0 |
Working assets | 18,2 | 37,1 | 127,5 | 243,9 |
Equity capital | -54,5 | -72,5 | -96,9 | -33,7 |
Basic operational activity income | 0 | 0 | 4 | -∞ |
% | % | % | p.p. | |
Equity capital to total assets | -23,4 | -30,6 | -42,6 | -12 |
Gross profit margin | -610,4 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane